EMVision Medical Devices Ltd (ASX:EMV)
Australia
· Delayed Price · Currency is AUD 1.750
0.00 (0.00%)
Jul 4, 2025, 11:37 AM AEST
EMVision Medical Devices Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2017 - 2019 |
Operating Revenue | 7.9 | 11.15 | 6.96 | 4 | 1.56 | 1.41 | Upgrade
|
Other Revenue | 0.16 | 0.07 | 0.02 | 0.36 | 0.14 | 0.14 | Upgrade
|
| 8.06 | 11.22 | 6.97 | 4.36 | 1.7 | 1.55 | Upgrade
| |
Revenue Growth (YoY) | -7.07% | 60.89% | 59.92% | 156.66% | 9.50% | 9.69% | Upgrade
|
Gross Profit | 8.06 | 11.22 | 6.97 | 4.36 | 1.7 | 1.55 | Upgrade
|
Selling, General & Admin | 8.04 | 7.26 | 6.45 | 5.86 | 3.38 | 2.05 | Upgrade
|
Research & Development | 4.66 | 4.7 | 2.01 | 2.33 | 2.71 | 2.94 | Upgrade
|
Other Operating Expenses | 0.23 | 0.23 | 0.21 | 0.16 | 0.05 | 0.01 | Upgrade
|
Operating Expenses | 13.98 | 13.48 | 10.93 | 10.47 | 10.18 | 5.11 | Upgrade
|
Operating Income | -5.92 | -2.26 | -3.96 | -6.11 | -8.49 | -3.56 | Upgrade
|
Interest Expense | -0.1 | -0.12 | -0.04 | -0.02 | -0.01 | -0 | Upgrade
|
Interest & Investment Income | 0.56 | 0.34 | 0.12 | 0.02 | 0.05 | 0.04 | Upgrade
|
EBT Excluding Unusual Items | -5.46 | -2.03 | -3.87 | -6.11 | -8.45 | -3.53 | Upgrade
|
Other Unusual Items | - | - | - | - | 0.05 | 0.05 | Upgrade
|
Pretax Income | -5.46 | -2.03 | -3.87 | -6.11 | -8.4 | -3.48 | Upgrade
|
Income Tax Expense | 0.73 | 0.7 | - | - | - | - | Upgrade
|
Net Income | -6.19 | -2.73 | -3.87 | -6.11 | -8.4 | -3.48 | Upgrade
|
Net Income to Common | -6.19 | -2.73 | -3.87 | -6.11 | -8.4 | -3.48 | Upgrade
|
Shares Outstanding (Basic) | 84 | 80 | 78 | 75 | 70 | 61 | Upgrade
|
Shares Outstanding (Diluted) | 84 | 80 | 78 | 75 | 70 | 61 | Upgrade
|
Shares Change (YoY) | 12.67% | 3.51% | 3.35% | 7.27% | 14.16% | 30.76% | Upgrade
|
EPS (Basic) | -0.07 | -0.03 | -0.05 | -0.08 | -0.12 | -0.06 | Upgrade
|
EPS (Diluted) | -0.07 | -0.03 | -0.05 | -0.08 | -0.12 | -0.06 | Upgrade
|
Free Cash Flow | -9.6 | -6.11 | 0.65 | -3.97 | -4.62 | -3.26 | Upgrade
|
Free Cash Flow Per Share | -0.11 | -0.08 | 0.01 | -0.05 | -0.07 | -0.05 | Upgrade
|
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
Operating Margin | -73.43% | -20.12% | -56.72% | -140.05% | -499.48% | -229.59% | Upgrade
|
Profit Margin | -76.77% | -24.33% | -55.51% | -140.11% | -494.37% | -224.03% | Upgrade
|
Free Cash Flow Margin | -119.13% | -54.43% | 9.28% | -91.12% | -272.05% | -209.82% | Upgrade
|
EBITDA | -5.75 | -2.09 | -3.83 | -6.03 | -8.47 | - | Upgrade
|
EBITDA Margin | -71.27% | -18.64% | -54.90% | -138.34% | - | - | Upgrade
|
D&A For EBITDA | 0.17 | 0.17 | 0.13 | 0.07 | 0.02 | - | Upgrade
|
EBIT | -5.92 | -2.26 | -3.96 | -6.11 | -8.49 | -3.56 | Upgrade
|
EBIT Margin | -73.43% | -20.12% | -56.72% | -140.05% | - | -229.59% | Upgrade
|
Revenue as Reported | 11.56 | 11.56 | 7.09 | 4.38 | 1.8 | 1.64 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.